Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 28;26(3):106296.
doi: 10.1016/j.isci.2023.106296. eCollection 2023 Mar 17.

Neuronal loss of NCLX-dependent mitochondrial calcium efflux mediates age-associated cognitive decline

Affiliations

Neuronal loss of NCLX-dependent mitochondrial calcium efflux mediates age-associated cognitive decline

Pooja Jadiya et al. iScience. .

Abstract

Mitochondrial calcium overload contributes to neurodegenerative disease development and progression. We recently reported that loss of the mitochondrial sodium/calcium exchanger (NCLX), the primary mechanism of mCa2+ efflux, promotes mCa2+ overload, metabolic derangement, redox stress, and cognitive decline in models of Alzheimer's disease (AD). However, whether disrupted mCa2+ signaling contributes to neuronal pathology and cognitive decline independent of pre-existing amyloid or tau pathology remains unknown. Here, we generated mice with neuronal deletion of the mitochondrial sodium/calcium exchanger (NCLX, Slc8b1 gene), and evaluated age-associated changes in cognitive function and neuropathology. Neuronal loss of NCLX resulted in an age-dependent decline in spatial and cued recall memory, moderate amyloid deposition, mild tau pathology, synaptic remodeling, and indications of cell death. These results demonstrate that loss of NCLX-dependent mCa2+ efflux alone is sufficient to induce an Alzheimer's disease-like pathology and highlights the promise of therapies targeting mCa2+ exchange.

Keywords: Behavioral neuroscience; Cellular neuroscience; Cognitive neuroscience; Molecular neuroscience.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interests related to this work. J.W.E. is a paid consultant for Mitobridge, Inc., An Astellas Company.

Figures

None
Graphical abstract
Figure 1
Figure 1
Loss of NCLX-dependent neuronal mCa2+ efflux promotes cognitive decline (A) Schematic of NCLX-nKO mice (NCLXfl/fl x Camk2a-Cre) mutant mouse strategy. (B and C) (B) NCLX mRNA expression in tissue isolated from the frontal cortex of NCLX-nKO and age-matched controls (Camk2a-Cre). mRNA expression corrected to the housekeeping gene Rps13; expressed as fold change versus control, n = 3 for both groups. All data presented as mean ± SEM; ∗∗∗p<0.001; two-tailed, unpaired t-test(C). Western blots for NCLX expression in tissue isolated from the cortex of 2-month-old NCLXfl/fl x Camk2a-Cre mice compared to age-matched control Camk2a-Cre mice. VDAC, voltage-dependent anion channel, served as mitochondrial loading controls. (D) NCLX protein expression expressed as fold-change versus Camk2a-Cre con. corrected to a mitochondrial loading control VDAC in brain cortex of 2-month-old mice. All data presented as mean ± SEM; ∗∗p<0.01; two-way ANOVA with Sidak’s multiple comparisons test. (E and F) Y-maze spontaneous alternation test. (E) Percentage of spontaneous alternation. (F) Total number of arm entries. (G–I) Fear-conditioning test. (G) Freezing responses in the training phase. (H) Contextual recall freezing responses, (I). Cued recall freezing responses. n = individual dots shown for each group in all graphs. All data presented as mean ± SEM. Data for percentage alternations, contextual and cued recall freezing response was analyzed using Prism (GraphPad) two-way ANOVA multiple comparison testing for an age effect with Dunnett’s post-hoc test for comparison to age 6 months and comparison of genotype across all ages using a Bonferroni’s multiple comparisons test, ∗∗p < 0.01. All comparisons were non-significant except those denoted. To ensure equivalent motor activity and behavior in the Y-maze and equivalent training for fear-conditioning behavioral testing data for Y-maze number of entries and freezing during training was analyzed using two-way ANOVA testing for comparison of genotype across all ages using a Bonferroni’s multiple comparisons test. No statistical differences were noted.
Figure 2
Figure 2
Loss of neuronal NCLX increases Aβ accumulation (A and B) Soluble and insoluble Aβ1–40 and Aβ1–42 levels in the cortex of 16-month-old mice, measured by sandwich ELISA. n = individual dots are shown for each group in all graphs. All data presented as mean ± SEM; ∗∗∗∗p<0.001, ∗∗p<0.01, ∗p<0.05; two-way ANOVA with Sidak’s multiple comparisons test. (C) Western blots for full-length APP, ADAM-10, BACE1, PS1, Nicastrin, APH, and tubulin (loading control) from cortex of 16-month-old NCLX-nKO and control mice, n = 3 for all groups. (D) BACE-1 protein expression expressed as fold change versus Camk2a-Cre con. corrected to tubulin loading control from frontal cortex of 2-month-old mice. All data presented as mean ± SEM; ∗p<0.05; two-tailed, unpaired t-test.
Figure 3
Figure 3
Loss of NCLX increases tau-pathology (A) Representative western blots of soluble total tau (HT7), and phosphorylated tau at residues S202/T205 (AT8), T231/S235 (AT180), T181 (AT270), and S396 (PHF13) in cortex homogenates of 16-month-old mice, n = 3 for all groups. (B–E) Densitometric analysis of western blots shown in Figure 3A expressed as fold-change versus Camk2a-Cre con. Corrected to a loading control tubulin. (F) Representative immunohistochemical staining for total tau (HT7) and phospho-tau T231/S235 (AT180) in hippocampus of NCLX-nKO and control mice; scale bar = 50 μM. (G and H) Quantification of the integrated optical density area of HT7 and AT180 immunoreactivity, n = 4 for all groups. All data presented as mean ± SEM; ∗∗p<0.01, ∗p<0.05; two-tailed, unpaired t-test.
Figure 4
Figure 4
Neuronal loss of mCa2+ efflux leads to redox imbalance, decreased synaptic stability and neuronal loss (A) Representative images of 4-HNE immunohistochemical staining in cortex and hippocampus of 16-month-old NCLX-nKO and control mice. (B) Percent change in 4-HNE-integrated optical density area corrected to Camk2a-Cre controls. N = 4 for all groups, scale bar = 50 μM. (C) Western blots for SYP and PSD-95 expression in tissue isolated from the cortex of 16-month-old-mice, n = 3 for all groups. (D and E) Densitometric analysis of western blots shown in Figure 4C, expressed as fold change versus Camk2a-Cre con. corrected to loading control tubulin. (F) Representative image of Nissl staining in cortex and hippocampus of 16-month-old mice to detect neuronal density. (G and H) Quantitative analysis of Nissl positive cells in cortex and hippocampus areas of brain sections expressed as percent change versus Camk2a-Cre controls. n = 4 for all groups, scale bar = 50 μM. (I) Western blots for GFAP and IBA1 expression in cortex of 16-month-old-mice, n = 3 for all groups. (J and K) Densitometric analysis of western blots shown in Figure 4I, expressed as fold change versus Camk2a-Cre con. corrected to loading control β-actin. All data presented as mean ± SEM; ∗∗p<0.01, ∗p<0.05; two-tailed, unpaired t-test.
Figure 5
Figure 5
Loss of NCLX increases mCa2+ overload, aggregate formation, and cell death (A) Schematic for generation of NCLX knockout cell line (NCLX−/−) using CRISPR/SpCas9. (B) NCLX mRNA expression in NCLX−/− and controls (WT) N2a cells, corrected to the housekeeping gene, Rps13; expressed as fold change versus control, n = 3 for both groups. All data presented as mean ± SEM; ∗∗∗∗p<0.001; two-tailed, unpaired t-test. (C) Representative traces for basal mCa2+ content. (D and E) (D) Quantification of mCa2+ content, n = 3 for both groups. All data presented as mean ± SEM; ∗∗p<0.001; two-tailed, unpaired t-test(E). Representative recordings of mCa2+ retention capacity. (F and G) (F)Percent change in mCa2+ retention capacity versus N2a control cells, n = 3 for both groups. All data presented as mean ± SEM; ∗p<0.05; two-tailed, unpaired t-test(G). Representative images of intracellular protein aggregates in NCLX−/− and WT cells stained with Proteostat aggresome detection reagent (red) and Hoechst 33,342 nuclear stain (blue), scale bars = 20-μm. (H) Total aggregates per cell, n = 96 for NCLX−/− and n = 58 for WT N2a control. All data presented as mean ± SEM; ∗∗∗∗p<0.001; two-tailed, unpaired t-test. (I and J) NCLX−/− and WT cells were assessed for plasma membrane rupture, Sytox Green, after treatment with (I). Ionomycin (10–40 μM), (J). thapsigargin (10–50 μM), n = 10 for both groups. All data presented as mean ± SEM; ∗∗∗p<0.001, ∗∗p<0.01, ∗p<0.05; two-way ANOVA with Sidak’s multiple comparisons test.

References

    1. Harman D. The biologic clock: the mitochondria? J. Am. Geriatr. Soc. 1972;20:145–147. doi: 10.1111/j.1532-5415.1972.tb00787.x. - DOI - PubMed
    1. Sun N., Youle R.J., Finkel T. The mitochondrial basis of aging. Mol. Cell. 2016;61:654–666. doi: 10.1016/j.molcel.2016.01.028. - DOI - PMC - PubMed
    1. Jack C.R., Jr., Bennett D.A., Blennow K., Carrillo M.C., Dunn B., Haeberlein S.B., Holtzman D.M., Jagust W., Jessen F., Karlawish J., et al. NIA-AA Research Framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018;14:535–562. doi: 10.1016/j.jalz.2018.02.018. - DOI - PMC - PubMed
    1. Mehta D., Jackson R., Paul G., Shi J., Sabbagh M. Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015. Expert Opin. Investig. Drugs. 2017;26:735–739. doi: 10.1080/13543784.2017.1323868. - DOI - PMC - PubMed
    1. Panza F., Lozupone M., Watling M., Imbimbo B.P. Do BACE inhibitor failures in Alzheimer patients challenge the amyloid hypothesis of the disease? Expert Rev. Neurother. 2019;19:599–602. doi: 10.1080/14737175.2019.1621751. - DOI - PubMed

LinkOut - more resources